HOME >> MEDICINE >> NEWS
Full-term, low-birth-weight babies at significantly greater risk for early respiratory symptoms

Through age 5, children born at full term with low birth weight show significantly greater risk for developing respiratory symptoms, including wheezing, coughing and pulmonary infections, according to a large longitudinal study on birth weight and development. The children's symptoms grew worse if they were exposed to environmental tobacco smoke.

The research results appear in the second issue for May 2007 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.

Professor Johan C. de Jongste, M.D., Ph.D., of the Department of Pediatric Respiratory Medicine at Erasmus MC/Sophia Children's Hospital in The Netherlands, and eight associates studied 3,628 children who took part in the 1996 Prevention and Incidence of Asthma and Mite Allergy (PIAMA) birth cohort study, which analyzed children's allergic reactions and history of asthma.

The researchers concluded that the effect of birth weight on respiratory symptoms increased, from ages 1 to 5, in direct relation to birth weight per kilogram less in each child. However, after age 5, the effect lessened and was not significant by age 7. The authors defined low birth weight as 5.5 pounds at birth.

"Size and maturity are major factors in the development of the lung," said Dr. de Jongste. "In children with diminished prenatal growth, and consequently low birth weight, a disturbed lung development is associated with a relatively small airway caliber. This can cause decreased lung function and more respiratory symptoms later in life."

According to the investigators, the effect of birth weight on respiratory symptoms was significantly greater among children exposed to tobacco smoke in their home. They also noted that maternal smoking during pregnancy was "clearly associated with a reduced birth weight."

By age 2, cough was the most frequently reported symptom among the children. Between the ages of 4 and 7, abou
'"/>

Contact: Suzy Martin
smartin@thoracic.org
212-315-8631
American Thoracic Society
15-May-2007


Page: 1 2

Related medicine news :

1. Commonly used drug offers promise for premature babies
2. Thymus transplants gives hope to babies with fatal immune disease
3. Probiotics could prevent necrotising enterocolitis in premature babies
4. A revolution in the monitoring of unborn babies
5. Improved neonatal care has helped reduce prevalence of cerebral palsy in premature babies
6. Solvent exposure linked to birth defects in babies of male painters
7. Low birth weight babies with reduced occipital regional volumes at higher risk for visual impairment
8. Examination not sensitive enough to detect breech babies
9. Breastfed babies cope better with stress in later life than bottle fed babies
10. Lung disease study hope for premature babies
11. Abnormal pattern of brain development in premature babies

Post Your Comments:
(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... a study published today in PLOS Pathogens , ... malaria is common can mount an immune response to ... avoid repeated bouts of high fever and illness and ... bloodstream. The findings may help researchers develop future interventions ... malaria parasite. , Each year, approximately 200 million cases ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... 2014 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... revenues for the fourth quarter of 2013 will be ... approximately $208 million. "Our full-year revenue growth ...
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: